Corbus Pharmaceuticals Holdings, Inc. ( CRBP) Discusses Phase 1a Single-Ascending and Multiple-Ascending Dose Data December 11, 2025 8:00 AM EST ...

Dec 8 (Reuters) - The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help ...

The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their ...

Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...

Biphenomycins, natural products derived from bacteria, show excellent antimicrobial activity, but have long remained out of ...

Clinical trials for drug development are notoriously slow and expensive, and only a small fraction of drug candidates end up being approved by the regulatory authorities. The extensive bottlenecks in ...

New York startup to use new chemistry process, AI and robotics to make drug compounds in the U.S.

Diabetes goes beyond just glucose control, and recent advancements in research are enhancing drug development for the disease.

Researchers at New York University Abu Dhabi (NYUAD) have developed Spheromatrix, a simple and low-cost technology that ...

Cell-free protein synthesis (CFPS) systems are a powerful platform with immense potential in fundamental research, biotechnology, and synthetic biology. Conventional prokaryotic CFPS systems, ...

Objectives Functional foods have demonstrated potential in preventing gastrointestinal and musculoskeletal (osteo-related) ...

If you’ve been on social media, you may have heard the buzz about “honey packs.” These honey supplements are mixed with various ingredients and advertised to enhance male sexual performance and fix ...